Observation study on patients with unicentric form of Castleman disease, evaluation of surgical treatment benefit. Observation of surgical treatment strategy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
5 year survival
Timeframe: each 6 months checkup, up to 150 weeks, from date of randomization until the date of first documented progression
recurence rate
Timeframe: each 6 months checkup, up to 150 weeks, from date of randomization until the date of first documented progression